Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33

Clinical trial NCT01864902 · UNKNOWN

Trial details

NCT number: NCT01864902
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Adult Myeloid Leukemia Chemotherapy Refractory Adult Myeloid Leukemia

Start date: 2013-04-01
Primary completion: 2016-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.